过去一年中添加的文章,按日期排序

Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older

S Yagishita, Y Yamanaka, T Kurata… - Clinical Pharmacology … - Wiley Online Library
3 天前 - … In 99 patients aged ≥75 years, PK was determined by liquid chromatography–mass
spectrometry on pretreatment samples. Performance status (PS), geriatric assessment (GA)…

БЮЛЛЕТЕНЬ СИБИРСКОЙ МЕДИЦИНЫ

ЕС ГЕРШТЕЙН, ОВ КОВАЛЕВА… - БЮЛЛЕТЕНЬ …, 2024 - elibrary.ru
7 天前 - … adenocarcinoma, 29 - as squamous-cell carcinoma, 11 - as small-cell LC (SCLC),
and 2 - as large-cell lung carcinoma. The pre-treatment KISS1 level in the blood serum was …

… of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer

A Tamiya, M Osuga, D Harada, S Isa, Y Taniguchi… - papers.ssrn.com
8 天前 - … observational study involved chemotherapy-naive patients with advanced non-small
cell lung cancer receiving osimertinib. Mutations in cancer-associated genes, detected via …

Early Noninvasive Tracking of Response to Targeted Therapy in Non-Small Cell Lung Cancer

H Husain, K Lu, B Woodward, R Singhrao, M Javey… - 2024 - researchsquare.com
10 天前 - … samples of 25 patients with advanced nonsmall cell lung cancer and observed …
tumor DNA on therapy. We evaluated pre-treatment and post-treatment specimens from patients

[HTML][HTML] High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)

MK Moutafi, KM Bates, TN Aung, RG Milian… - … of Cancer, 2024 - ncbi.nlm.nih.gov
10 天前 - … We analyzed retrospectively collected baseline/pretreatment FFPE tumor specimens
represented in four tissue microarrays (TMA) format from 56 patients with NSCLC treated …

Prognostic Value of Body Composition in Therapy-Naive Patients with Non-Small Cell Lung Cancer

T KIRATLI YOLCU, S KESİM… - UHOD-Uluslararasi …, 2024 - avesis.marmara.edu.tr
11 天前 - cell lung cancer (NSCLC) patients undergoing different therapy regimens. Eighty
three patientsPre-treatment multi-slice and single-slice computed tomography images of PET/…

Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer

T Hasegawa, T Okuyama, T Uemura, Y Matsuda… - … Care in Cancer, 2024 - Springer
11 天前 - patients with pretreated non-small cell lung cancer from four study sites. Patients
and their oncologists were asked whether they perceived the disclosure of cancer incurability. …

Differences in systemic immune parameters in individuals with lung cancer according to race

MS von Itzstein, J Liu, H Mu-Mosley, FJ Fattah, JY Park… - bioRxiv, 2024 - biorxiv.org
11 天前 - … Enrolled individuals underwent collection of clinical data and collection of pretreatment
patients with lung cancer. Although Black patients tended to have earlier-stage cancer

[PDF][PDF] Does Autoimmune Response Against Surfactant Protein Cause Interstitial Lung Disease?

S Watanabe, T Kikuchi - … Journal of Respiratory and Critical Care …, 2024 - atsjournals.org
14 天前 - … -cell antigens shared between skin and tumors (2). They showed that non-small cell
lung cancer (NSCLC) patients with T cells … in ICI-ILD patients in both pre-treatment and post-…

Sacituzumab govitecan (SG) vs docetaxel (doc) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) previously treated with platinum (PT)-based …

LG Paz-Ares, O Juan-Vidal, GS Mountzios, E Felip… - 2024 - ascopubs.org
15 天前 - … SG, a Trop-2-directed antibody drug conjugate, showed durable response and
tolerable safety in pretreated mNSCLC. We report results from the phase 3, randomized, open-…